HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.